Archived Publications Archives

← ALL PUBLICATIONS

Archived Publications

Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report

Invivoscribe Marketing2021-02-12T22:24:11-08:00December 29th, 2015|Archived Publications, Publications|

Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative

Invivoscribe Marketing2021-02-12T20:48:04-08:00December 1st, 2015|Archived Publications, Publications|

Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants

Invivoscribe Marketing2021-02-12T22:28:17-08:00August 10th, 2015|Archived Publications, Publications|

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

Invivoscribe Marketing2021-02-13T00:38:16-08:00March 18th, 2015|Archived Publications, Publications|

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

Invivoscribe Marketing2021-02-13T00:42:37-08:00August 15th, 2014|Archived Publications, Publications|

Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma

Invivoscribe Marketing2021-02-13T00:46:19-08:00August 13th, 2014|Archived Publications, Publications|

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

Invivoscribe Marketing2021-02-12T20:42:59-08:00April 5th, 2014|Archived Publications, Publications|

Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients

Invivoscribe Marketing2021-02-18T21:08:35-08:00November 15th, 2013|Archived Publications, Publications|

Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma

Invivoscribe Marketing2021-02-18T21:10:55-08:00October 31st, 2013|Archived Publications, Publications|

Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia?

Invivoscribe Marketing2021-02-18T21:14:44-08:00October 25th, 2013|Archived Publications, Publications|

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay

Invivoscribe Marketing2021-02-18T21:18:36-08:00October 25th, 2013|Archived Publications, Publications|

Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement

Invivoscribe Marketing2021-02-18T21:22:32-08:00August 13th, 2013|Archived Publications, Publications|

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

Invivoscribe Marketing2021-02-18T21:25:10-08:00October 26th, 2012|Archived Publications, Publications|

A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology

Invivoscribe Marketing2021-02-18T22:35:18-08:00January 11th, 2012|Archived Publications, Publications|

Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings

Invivoscribe Marketing2021-02-18T22:37:16-08:00December 10th, 2011|Archived Publications, Publications|

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

Invivoscribe Marketing2021-02-18T22:40:02-08:00March 30th, 2011|Archived Publications, Publications|

Molecular Diagnostics of Hematologic Malignancies

Invivoscribe Marketing2021-02-18T22:44:51-08:00September 2nd, 2009|Archived Publications, Publications|

IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations

Invivoscribe Marketing2021-02-18T22:47:08-08:00April 26th, 2006|Archived Publications, Publications|

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V–J and V–D–J JUNCTIONs

Invivoscribe Marketing2021-02-18T22:53:47-08:00August 4th, 2004|Archived Publications, Publications|

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

January 25th, 2024 Leveraging Standardized MRD Assays to Guide CLL Treatment

March 23rd, 2023 Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report

Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative

Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients

Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma

Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia?

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay

Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology

Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

Molecular Diagnostics of Hematologic Malignancies

IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V–J and V–D–J JUNCTIONs

Title

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

March 1st, 2024 Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing–Based Clonality Testing in B-Cell and Plasma Cell Neoplasms

January 25th, 2024 Leveraging Standardized MRD Assays to Guide CLL Treatment

March 23rd, 2023 Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

Title

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.